Key result
Transcatheter closure of multiple ASDs achieves ~92% complete closure at follow-up.
Why the study?
Multiple atrial septal defects often present with an atrial septal aneurysm or long interdefect distance, prompting a review of different closure strategies.
Does individualized percutaneous transcatheter closure effectively and safely treat multiple atrial septal defects?
Observational (n=50)
No
Does individualized percutaneous transcatheter closure effectively and safely treat multiple atrial septal defects?
Individualized percutaneous transcatheter closure strategies for multiple ASDs are effective and safe, achieving a 92% complete closure rate at mid- to long-term follow-up.
Individualized transcatheter strategies for multiple ASDs appear feasible; leaves open optimal device selection pending prospective trials.
Multiple atrial septal defects (ASDs) are one type of secundum ASD, most of which have an atrial septal aneurysm or long interdefect distance. In our retrospective single-center study, we reviewed different closure strategies for multiple ASDs. We analyzed 50 patients who underwent percutaneous transcatheter closure from May 2011 to July 2019. Information on the patients' characteristics, operation procedure, occluder selection, and complications was collected. According to the feature of the defects and device choice, multiple ASDs were divided into five groups. A successful operation was achieved in every patient. A total of 50 patients were implanted with 58 devices, with 26 patients implanted with a single standard ASD occluder (ASDO); six patients were implanted with double standard ASDOs, and only one patient was implanted with three standard ASDOs. There were 17 patients whose closure was made using the small-waist-big-edge ASDO. Seventy-six percent of the patients (38/50) had an immediate residual shunt. During the mean follow-up of 25.76 ± 22.53 months, the complete closure rate was 92%. Except for two patients with a transient atrioventricular block, individualized experience with percutaneous transcatheter closure for multiple ASDs was effective in a single-center study. After a mid- to long-term follow-up, the multiple ASDOs and small-waist-big-edge ASDO had no serious adverse events or complications.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) conducted an observational in Multiple atrial septal defects (n=50). Percutaneous transcatheter closure was evaluated on Complete closure rate. Percutaneous transcatheter closure of multiple atrial septal defects achieved an immediate complete closure rate of 76% and a 92% complete closure rate during a mean follow-up of 25.8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: